Our History


Important Achievements and Milestones of our Company:

2012:  The Company was founded in Guangzhou

2013:  The Company founded two JV companies, Dongguan ZhenxinBetter Medicine Technology Co. Ltd. and Guangzhou Kegene Drug Development Company Co. Ltd.;  Dr. Changgeng Qian was honored as a National Expert of “the Thousand Talents Plan” and Guangzhou City Development Zone Entrepreneurial Leading Talent (Grant awarded 15 million RMB) .

2014:  The Company moved into a state-of-the-art new drug research and development facility and started a number of new drug discovery programs.

2015:  IND application for BEBT-908, a Class 1.1 (Chinese SFDA classification) anticancer drug, was approved by CFDA; The company’s returnee innovation team was awarded the prestigious “Introduced Innovative and Entrepreneurial Team of Guangdong Province”. With matching award from the Guangzhou City Government, the award totaled 90 million RMB.

2016:  A phase I clinical trial of BEBT-908 in the treatment of relapsed and refractory lymphatic hematologic malignancies was initiated at Xiangya Hospital and Hunan Cancer Hospital, both nationally acclaimed hospitals affiliated with Central South University in Changsha, China.

2017:  The Company acquired the Guangzhou Kegene Drug Development Co. Ltd. ; BEBT-908 clinical development program was selected as one of the prestigious “National Major Scientific and Technological Special Project for “Significant New Drugs Development” during the 13th Five-year Plan Period”. (Grant Awarded about 10 million RMB); Three new anti-tumor drug candidates were advanced into IND-enabling studies.